Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Objective evaluation of sedative effects of Yokukansan using saccadic eye movements in healthy Japanese males
jRCTs031220185Completed
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of yokukansan in None (3 arms). Primary endpoint: Saccadic eye movement peak velocity. Started Jul 2022; status: completed.
02
Drugs
yokukansan
Beyond the preview
Go deeper on jRCTs031220185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220185.